总之，合理有效的眼部处理随着时间的推移眼确保在 MIC90即1至2毫克/升长期对病原体的最佳曝光，在与眼部发炎患者房水中提供了系统性左氧氟沙星试验支持术后眼内炎的预防在选定的病人或为这一潜在的毁灭性的感染并发症的辅助治疗。

　　　　致谢

　　　　这个项目能够进行研究，对于（DPMSC，乌迪内大学）政府部门的资金。Di,Terlizzi的技术和Eliana协助,在此深表感谢。

　　　　参考文献

　　[1] Benz, M. S., I. U. Scott, H. W. Flynn, Jr., N. Unonius, and D. Miller. 2004. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am. J. Ophthalmol. 137: 38-42.

　　[2] Blondeau, J. M. 1999. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones. J. Antimicrob. Chemother. 43 (Suppl. B) : 1-11.

　　[3] Bucci, F. A., Jr. 2004. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. Am. J. Ophthalmol. 137: 308-312.

　　[4] Callegan, M. C., M. Engelbert, D. W. Parke II, B. D. Jett, and M. S. Gilmore. 2002. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin. Microbiol. Rev. 15: 111-124.

　　[5] Chisari, G., G. Cavallaro, M. Reibaldi, and S. Biondi. 2004. Presurgical antimicrobial prophylaxis: effect on ocular flora in healthy patients. Int. J. Clin. Pharmacol. Ther. 42: 35-38.

　　[6] Ciulla, T. A., M. B. Starr, and S. Masket. 2002. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 109: 13-24.

　　[7] Cockcroft, D. W., and M. H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.

　　[8] Colin, J., S. Simonpoli, K. Geldsetzer, and A. Ropo. 2003. Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin. Acta Ophthalmol. Scand. 81: 611-613.

　　[9] Colleaux, K. M., and W. K. Hamilton. 2000. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can. J. Ophthalmol. 35: 373-378.

　　[10] Donnenfeld, E. 论文范文http://www.chuibin.com/ D., H. D. Perry, R. W. Snyder, R. Moadel, M. Elsky, and H. Jones. 1997. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch. Ophthalmol. 115: 173-176.

　　[11] Eifrig, C. W., I. U. Scott, H. W. Flynn, Jr., and D. Miller. 2003. Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology 110: 1714-1717.

　　[12] Fiscella, R. G., T. K. Nguyen, M. J. Cwik, B. A. Phillpotts, S. M. Friedlander, D. C. Alter, M. J. Shapiro, N. P. Blair, and J. P. Gieser. 1999. Aqueous and vitreous penetration of levofloxacin after oral administration. Ophthalmology 106: 2286-2290.

　　[13] Fisch, A., A. Salvanet, T. Prazuck, F. Forestier, L. Gerbaud, G. Coscas, C. Lafaix, and The French Collaborative Study Group on Endophthalmitis. 1991. Epidemiology of infective endophthalmitis in France. Lancet 338: 1373-1376.

　　[14] Fukuda, M., A. Inoue, K. Sasaki, and N. Takahashi. 2004. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution. Jpn. J. Ophthalmol. 48: 93-96.

　　[15] Garcia-Saenz, M. C., A. Arias-Puente, M. J. Fresnadillo-Martinez, and C. Carrasco-Font. 2001. Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin. J. Cataract Refract. Surg. 27: 1969-1974.

　　[16] Han, D. P., S. R. Wisniewski, L. A. Wilson, M. Barza, A. K. Vine, B. H. Doft, and S. F. Kelsey. 1996. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am. J. Ophthalmol. 122: 1-17.

　　[17] Hanioglu-Kargi, S., N. Basci, H. Soysal, A. Bozkurt, E. Gursel, and O. Kayaalp. 1998. The penetration of ofloxacin into human aqueous humor given by various routes. Eur. J. Ophthalmol. 8: 33-36.

　　[18] Hanscom, T. A. 2004. Postoperative endophthalmitis. Clin. Infect. Dis. 38: 542-546.

　　[19] Healy, D. P., E. J. Holland, M. L. Nordlund, S. Dunn, C. Chow, R. L. Lindstrom, D. Hardten, and E. Davis. 2004. Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea 23: 255-263.

　　[20] Javitt, J. C., D. A. Street, J. M. Tielsch, Q. Wang, M. M. Kolb, O. Schien, A. Sommer, M. Bergner, E. P. Steinberg, and the Cataract Patient Outcomes Research Team. 1994. National outcomes of cataract extraction. Retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology 101: 100-106.

　　[21] Herbert, E. N., I. A. Pearce, J. McGalliard, D. Wong, and C. Groenewald. 2002. Vitreous penetration of levofloxacin in the uninflamed phakic human eye. Br. J. Ophthalmol. 86: 387-389.

　　[22] Kattan, H. M., H. W. Flynn, Jr., S. C. Pflugfelder, C. Robertson, and R. K. Forster. 1991. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 98: 227-238.

　　[23] Kobayakawa, S., T. Tochikubo, and A. Tsuji. 2003. Penetration of levofloxacin into human aqueous humor. Ophthalmic Res. 35: 97-101.

　　[24] Kunimoto, D. Y., T. Das, S. Sharma, S. Jalali, A. B. Majji, U. Gopinathan, S. Athmanathan, T. N. Rao, and the Endophthalmitis Research Group. 1999. Microbiologic spectrum and susceptibility of isolates: Part I. Postoperative endophthalmitis. Am. J. Ophthalmol. 128: 240-242.

　　[25] Leaming, D. V., for the American Society of Cataract and Refractive Surgery. 2001. Practice styles and preferences of ASCRS members-2000 survey. J. Cataract Refract. Surg. 27: 948-955.

上一页  [1] [2]